In This Section

Program

Please note that this meeting will take place as an in-person event in Busan, Korea and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

[R] – Remote Presentation

Thursday, November 13

Friday, November 14

Thursday, November 13

Opening Remarks

8:20-8:30 a.m.

  • Ricky Johnstone, Peter MacCallum Cancer Centre, Australia
  • Se-Hoon Lee, Sungkyunkwan University School of Medicine, Korea

Educational Session 1: The evolution of cancer immunotherapy

8:30-10:10 a.m.

  • Drivers of response to cancer immunotherapy in time and space
    Francesca Ciccarelli, Barts Cancer Institute & The Francis Crick Institute, London, United Kingdom
  • Immunotherapy in breast cancer
    Sherene Loi, Peter MacCallum Cancer Centre, Victoria, Australia
  • Seung-Woo Lee, Pohang University of Science and Technology, Korea
  • Hye Ryun Kim, Yonsei University College of Medicine, Korea

Break

10:10-10:30 a.m.

Waun Ki Hong Memorial Lecture 

10:30-11:10 a.m.

  • Introduction of Waun Ki Hong Memorial Lecturer
  • Se-Hoon Lee, Sungkyunkwan University School of Medicine, Korea                           
  • A journey through the pivotal milestones of precision oncology: The mentor’s guidance       
    Hyun Cheol Chung, Yonsei University College of Medicine

Break

11:10-11:20 a.m.

Luncheon Symposia

11:20 a.m.-12 p.m.

Poster Session A / Break

12-12:30 p.m.

Plenary Session 1: Advances in cancer vaccine therapy: personalized, public, and immune-targeted approaches

12:30-2:10 p.m.

Session Cochair: Mark Yarchoan, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

  • Therapeutic neoantigen vaccines to overcome intrinsic PD1 resistance
    Mark Yarchoan
  • Jung Kyoon Choi, Korea Advanced Institute of Science and Technology, Korea
  • Kyong Hwa Park, Korea University College of Medicine, Korea

Break

2:10-2:30 p.m.

Plenary Session 2: Radioconjugates (theranostics) and antibody-drug conjugates: precision in targeted cancer therapy

2:30-4:10 p.m.

Session Cochair: Cathy S. Cutler, Brookhaven National Laboratory

  • Overview of radionuclide targeted therapy of neuroendocrine tumors
    Cathy S. Cutler, Brookhaven National Laboratory, Upton, New York, USA
  • Hee Kyung Ahn, Sungkyunkwan University School of Medicine, Korea
  • Ilhan Lim, Korea Institute of Radiological and Medical Sciences, Korea

Break

4:10-4:30 p.m.

Proffered Papers Session

4:30-5:30 p.m.

Faculty dinner

6:30 p.m.

Friday, November 14

Educational Session 2: Genomic testing – from discovery to advanced cancer care

8-9:30 a.m.

  • Molecular second opinions
    Sean Grimmond, University of Melbourne, Melbourne, Australia
  • Expanding the actionable genome
    David B. Solit, Memorial Sloan Kettering Cancer Center, New York, USA
  • Jihun Kim, University of Ulsan College of Medicine, Korea

Break

9:30-9:40 a.m.

Plenary Session 3: Protein degradation – PROTACS and molecular glues

9:40-11:20 a.m.

Session Cochair: Zoran Rankovic, The Institute of Cancer Research

  • Expanding the druggable proteome with molecular glue degraders
    Eric S. Fischer, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
  • Exploring the CRBN neosubstrate landscape for cancer therapies
    Zoran Rankovic, The Institute of Cancer Research, London, United Kingdom
  • Hwa Jin Lee, Kyung Hee University School of Medicine, Korea
  • Jaewhan Song, Yonsei University, Korea

Break

11:20-11:40 a.m.

Keynote Lecture

11:40 a.m.-12:20 p.m.

  • Introduction of Keynote Lecture
    Ricky Johnstone, Peter MacCallum Cancer Centre, Australia
  • Ageing and environmental exposures drive tumor initiation and progression
    Charles Swanton, The Francis Crick Institute, London, England

Break

12:20-12:30 p.m.

Luncheon Symposia

12:30-1:10 p.m.

Poster Session B / Break

1:10-1:40 p.m.

Posters will be on display from 08:30-17:30 with official viewing session from 13:10-13:40

Plenary Session 4: Advances in precision medicine in hematological malignancies

1:40-3:20 p.m.

Session Cochair: Ann-Kathrin Eisfeld, Ohio State University

  • Early detection and therapeutic targeting of extramedullary acute leukemia
    Ann-Kathrin Eisfeld
  • Targeting chromatin complexes in cancer
    Scott Armstrong, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
  • Youngil Koh, Seoul National University College of Medicine, Korea
  • Semin Lee, Ulsan National Institute of Science and Technology, Korea

Break

3:20-3:40 p.m.

Plenary Session 5: AI and machine learning in oncology: transforming cancer research and treatment

3:40-5:20 p.m.

Session Chair: Faisal Mahmood, Harvard Medical School, Boston, Massachusetts, USA

  • Multimodal, generative, and agentic AI for pathology
    Faisal Mahmood
  • Characterizing germline cancer mechanisms at scale: risk, tumor evolution, and treatment outcomes
    Alexander Gusev, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
  • Joo Kyung Park, Sungkyunkwan University School of Medicine, Korea
  • Joon Beom Seo, University of Ulsan College of Medicine, Korea

Awards and Closing Ceremony

5:20 p.m.